Trends in Utilization of Outpatient Respiratory Syncytial Virus Prophylaxis with Palivizumab among Medicaid- and Commercially Insured Infants

por Pavilack, Melissa, Clifford, Robert A., Gonzales, Tara, Kong, Amanda M., Wade, Sally, McLaurin, Kimmie K.
Publicado 2017

Adverse event rates and economic burden associated with purine nucleoside analogs in patients with hairy cell leukemia: a US population-retrospective claims analysis

por Epperla, Narendranath, Pavilack, Melissa, Olufade, Temitope, Bashyal, Richa, Li, Jieni, Kabadi, Shaum M., Yuce, Huseyin, Andritsos, Leslie
Publicado 2020

Chronologic Age at Hospitalization for Respiratory Syncytial Virus Among Preterm and Term Infants in the United States

por Parikh, Rohan C., McLaurin, Kimmie K., Margulis, Andrea V., Mauskopf, Josephine, Ambrose, Christopher S., Pavilack, Melissa, Candrilli, Sean D.
Publicado 2017

Impact of Respiratory Syncytial Virus–Confirmed Hospitalizations on Caregivers of US Preterm Infants

por Pokrzywinski, Robin M., Swett, Laura L., Pannaraj, Pia S., Yi, Jumi, Pavilack, Melissa S., Kumar, Veena R., McLaurin, Kimmie K.
Publicado 2019

EGFR mutation testing and treatment decisions in patients progressing on first- or second-generation epidermal growth factor receptor tyrosine kinase inhibitors

por Chiang, Anne C., Fernandes, Ancilla W., Pavilack, Melissa, Wu, Jennifer W., Laliberté, François, Duh, Mei Sheng, Chehab, Nabil, Subramanian, Janakiraman
Publicado 2020

The 2014–2015 National Impact of the 2014 American Academy of Pediatrics Guidance for Respiratory Syncytial Virus Immunoprophylaxis on Preterm Infants Born in the United States

por Kong, Amanda M., Krilov, Leonard R., Fergie, Jaime, Goldstein, Mitchell, Diakun, David, Wade, Sally W., Pavilack, Melissa, McLaurin, Kimmie K.
Publicado 2018